HIV Entry and Early Infection: Step-by-Step Pathogenesis

Understanding the early events of HIV infection clarifies why early treatment is transformative.

1. Transmission and Mucosal Entry

HIV in semen, vaginal fluid, blood, or breast milk crosses mucosal epithelium (or direct bloodstream entry). Dendritic cells (Langerhans cells) capture virus and carry it to lymph nodes.

2. Founder Virus and Local Replication

Typically a single viral variant establishes infection. Explosive replication in gut-associated lymphoid tissue (GALT) depletes CD4+ T cells there within days.

3. Acute HIV Syndrome (Seroconversion) — Weeks 2–4

~50–90% develop flu-like illness:

  • Fever, rash, pharyngitis, lymphadenopathy, myalgia, headache
  • High viral load (millions copies/mL); very infectious
  • CD4+ count drops transiently

Often misdiagnosed as flu, mono, or COVID.

4. Viral Set Point and Clinical Latency — Months to Years

Immune response partially controls virus. Viral load stabilizes at "set point" (predicts progression speed). CD4+ decline averages ~50–100 cells/year without ART. Asymptomatic but ongoing immune activation and reservoir seeding.

5. AIDS — CD4+ <200 cells/µL or AIDS-Defining Illness

Severe immunodeficiency → opportunistic infections, malignancies, wasting. Without ART, median survival ~1–3 years.

6. ART: Game Changer

  • Rapid viral suppression (<50 copies/mL in 8–24 weeks).
  • CD4+ recovery (average +50–150 cells/year initially).
  • Prevents transmission (U=U).
  • Normalizes life expectancy if started early and adhered to.

Test early, treat early. Same-day ART initiation is now standard of care.

HIV & AIDS - Related Articles